PAPA spectrum disorders [0.03%]
PA PA谱系障碍
Giovanni Genovese,Chiara Moltrasio,Simone Garcovich et al.
Giovanni Genovese et al.
Pyogenic arthritis, pyoderma gangrenosum (PG) and acne (PAPA) syndrome is an autosomal dominant autoinflammatory syndrome due to mutations in proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1) gene and presenting with cuta...
Blau Syndrome: NOD2-related systemic autoinflammatory granulomatosis [0.03%]
蓝氏综合征：NOD2相关系统性自身炎症肉芽肿病
Sanami Takada,Megumu K Saito,Naotomo Kambe
Sanami Takada
Blau Syndrome, or early-onset sarcoidosis, is hereditary juvenile-onset systemic granulomatosis. Clinical symptoms appear before the age of four years and mainly affect the skin, joints, and eyes. The symptoms are progressive and cause seve...
Oral therapies for psoriasis and psoriatic arthritis: current knowledge and future perspectives [0.03%]
银屑病和银屑病关节炎的口服疗法：目前的认识及未来展望
Tiago Torres
Tiago Torres
Jose-Manuel Carrascosa,Elena Del-Alcazar
Jose-Manuel Carrascosa
Apremilast is a small-molecule inhibitor of phosphodiesterase 4 with an intracellular mechanism of action that increases levels of cyclic adenosine monophosphate (cAMP) indicated for the oral treatment of moderate to severe plaque psoriasis...
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis [0.03%]
新型JAK抑制剂治疗银屑病和银屑病关节炎
Dario F D&#x;Urso,Andrea Chiricozzi,Federico Pirro et al.
Dario F D&#x;Urso et al.
Psoriasis is a common inflammatory skin disease that can be associated with various pathological conditions among which arthritis is a frequent comorbidity. Based on the current pathogenetic model, development of psoriasis is mainly driven ...
Giuseppe Pistone,Salvatrice Curiale,Maria R Bongiorno
Giuseppe Pistone
Prolidase deficiency is a rare disorder inherited through an autosomal recessive gene. The hallmark of the disorder are iminodipeptiduria, chronic skin ulcers, recurring infections, mental retardation and characteristic facial appearance, a...
Calcipotriol/betamethasone dipropionate aerosol foam in the treatment of psoriasis: new perspectives for the use of an innovative topical treatment from real-life experience [0.03%]
卡泊三醇/倍他米松双丙酸酯气雾剂泡沫治疗银屑病：真实世界经验下一种创新性局部用药的新视角
Gabriella Fabbrocini,Esteban Dauden,Ahmad Jalili et al.
Gabriella Fabbrocini et al.
The fixed-dose combination of calcipotriol/betamethasone dipropionate (Cal/BD foam) in aerosol foam formulation is approved for the treatment of plaque psoriasis, and showed prompt onset of action, persistent efficacy and safety both in cli...
Management of cutaneous melanoma: comparison of the leading international guidelines updated to the 8th American Joint Committee on Cancer staging system and workup proposal by the Italian Society of Dermatology [0.03%]
皮肤黑色素瘤的管理：基于美国联合委员会癌症分期系统的国际领先指南比较及意大利皮肤病学会检查程序建议
Giuseppe Argenziano,Gabriella Brancaccio,Elvira Moscarella et al.
Giuseppe Argenziano et al.
The Italian dermatologic community facing COVID-19 pandemic: recommendation from the Italian society of dermatology and venereology [0.03%]
意大利皮肤病学界应对新冠肺炎疫情：意大利皮肤性病学会建议
Giuseppe Micali,Maria L Musumeci,Ketty Peris;Board Members of the SIDeMaST
Giuseppe Micali
Arvin Ighani,Jorge R Georgakopoulos,Jensen Yeung
Arvin Ighani
Introduction: Tofacitinib is a novel oral janus kinase (JAK) inhibitor approved for the treatment of psoriatic arthritis. It was also investigated for the treatment of plaque psoriasis, although it is not approved by the ...